Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T16:12:59.932Z.
Calculation as of: 2026-10-06T16:12:59.932Z.
Quote observation: 2026-10-06T16:04:27.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c421eb3f9cbf80487861bd205397d7cf152d6c676755a2868786c2d5add3cf98
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
MBody AI Ltd.
Market Cap
$3.21M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| MBody AI Ltd. (MBAI) | $3.21M | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.23M | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.15M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.33M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.07M | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $3.04M | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.26M | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.39M | N/A |
| Evogene Ltd. (EVGN)vs › | $3.51M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.00M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
